PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA.\', \'Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, USA.\', \'Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.\', \'Servei de Neurologia-Neuroimmunologia, Centre d\'Esclerosi Múltiple de Catalunya, (CEMCAT), Vall d\'Hebron Institut de Recerca, Vall d\'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.\', \'Division of Neuroimmunology and Neurological Infections, Johns Hopkins University, Baltimore, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/1352458520948231
?:hasPublicationType
?:journal
  • Multiple sclerosis (Houndmills, Basingstoke, England)
is ?:pmid of
?:pmid
?:pmid
  • 32772807
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Multiple sclerosis management during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all